The September FAST UK newsletter shares the latest Angelman syndrome research news, clinical trial updates and community initiatives. It highlights new educational resources, guidance for families preparing for clinical trials, support for newly diagnosed families and fundraising opportunities, while encouraging continued awareness, involvement and connection across the Angelman community.

The FAST UK newsletter shares important developments in Angelman syndrome research, including progress in gene therapy, clinical trial updates and new approaches to measuring communication. It also highlights educational resources for families, International Angelman Day activities, community fundraising opportunities and ways to get involved in supporting research, raising awareness and connecting with the Angelman community.

The FAST UK newsletter highlights significant developments in Angelman syndrome research, including progress in gene therapy, breakthrough therapy designation for GTX-102 and updates on Phase 3 clinical trials. It also shares community fundraising achievements, awareness initiatives, upcoming scientific events and opportunities for families to get involved in supporting research and the wider Angelman community.

The March FAST UK newsletter shares updates on Angelman syndrome research, including planned Phase 3 clinical trials, alongside community news and awareness activities. Highlights include International Angelman Day celebrations, the Alton Towers family weekend, media awareness campaigns and opportunities for families to get involved, stay informed and connect with the wider Angelman community.

The December 2024 FAST UK newsletter shares the latest Angelman syndrome research developments, including updates on planned clinical trials, genetics education and scientific progress. It also highlights community stories, family experiences, awareness initiatives and resources designed to keep families informed, connected and supported.